Our study provides new insights into the role of neutrophils during acute exacerbation of MG, suggesting that inhibiting neutrophil‐derived BAFF secretion could serve as an effective targeted immunotherapy strategy, offering new treatment opportunities for MG patients. The gene discussed is TNFSF13B; the disease is myasthenia gravis.